MiR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway

Table 1 Correlation of miR-503 expression with clinicopathologic parameters in 46 GC patients

Clinicopathologic parameter	Total (n = 46)	MiR-503 expression level		P-value
Clinicopathologic parameter	Total (n = 46)	Lower (n = 24)	Higher (n = 22)	P-value
Age (years)				0.211
≤ 55	27	12	15
> 55	19	12	7
Gender				0.829
Male	30	16	14
Female	16	8	8
Tumor size				0.008*
< 3	24	8	16
≥ 3	22	16	6
Histological grade				0.686
High and middle	30	15	15
Low	16	9	7
Lymph node metastasis				0.017*
No	25	9	16
Yes	21	15	6
TNM stage				0.460
I/II	31	15	16
III/IV	15	9	6
Local invasion				0.143
T1, T2	22	9	13
T3, T4	24	15	9

ISSN: 1475-2867